News & Updates
Filter by Specialty:
Metformin may reduce COVID-19 severity in prediabetes, PCOS
Among patients with prediabetes or polycystic ovary syndrome (PCOS), the use of metformin appears to be associated with lower incidence of severe COVID-19, according to a study.
Metformin may reduce COVID-19 severity in prediabetes, PCOS
19 Dec 2022
Gestational diabetes mellitus predisposes women to prediabetes, T2DM
Among women with a history of gestational diabetes mellitus (GDM), the conversion to prediabetes or type 2 diabetes mellitus (T2DM) appears to be high, a recent study has found.
Gestational diabetes mellitus predisposes women to prediabetes, T2DM
19 Dec 2022
Coexisting diabetes ups risk of secondary malignancy, death in cancer patients
In cancer patients, the presence of diabetes appears to aggravate the likelihood of developing a secondary malignancy or death, reports a recent Japan study.
Coexisting diabetes ups risk of secondary malignancy, death in cancer patients
15 Dec 2022
Carotid atherosclerosis ups risk of small fibre nerve dysfunction in T2D
Among patients with type 2 diabetes (T2D), the presence of carotid atherosclerosis appears to aggravate the risk of developing small fibre nerve dysfunction, a recent study has found.
Carotid atherosclerosis ups risk of small fibre nerve dysfunction in T2D
14 Dec 2022
Diabetes and COVID-19: What have we learned so far?
Evidence for excess risk and increased burden of new-onset diabetes among COVID-19 survivors is robust, and most antihyperglycaemic drugs can be used safely during acute COVID-19, with some drugs potentially offering protection against serious complications, according to data presented at 5th EDM HK.
